O ver the last 2 decades, in both the US and Canada, an important debate has emerged within professional psychology about whether clinical psychologists should be granted the legal right to prescribe psychotropic medications. The American Psychological Association (APA) and both American and Canadian psychologists argue that psychologists cannot function as independent professionals, due to the many restrictions placed on their practice by the medical profession (1) (2) (3) . Proponents argue that prescription privileges (PPs) may significantly improve patient care and are in the best interests of the profession. Despite receiving considerable attention throughout the US, there has been relatively little discussion of this important debate among Canadian mental health professionals and professional legislative bodies.
Throughout the course of this paper, we present the major arguments for and against PPs for psychologists, followed by a discussion of the potential impact of PPs on both the professions of psychology and psychiatry. Given that psychiatrists will likely be consulted, we hope this article will help inform them about the major issues surrounding this debate.
History: The Prescription Privilege Debate
Lightner Witmer, who established the first American psychology clinic in 1896, originally founded clinical psychology. At that time, the practice of clinical psychology was conceived as the application of psychological principles to the study of the individual (4), but it remained a largely academic discipline until World War II. During and after the Second World War, the demand for mental health services to treat the victims of war increased dramatically, and the Veteran's Administration (VA) was forced to expand the role of psychologists to include psychometrics, interpretation of aptitude, intelligence, and personality tests, diagnostic interviewing, and psychiatristsupervised psychotherapy (5) . Interestingly, the APA's Committee on Training in Clinical Psychology (CTCP) (6) did not envision psychotherapy as a central activity for clinical psychologists. Training programs were designed to produce psychological scientists by emphasizing research, psychodiagnostics, and general psychology principles. Training clinicians was secondary in importance. Despite the intentions of the CTCP, many clinical psychologists wanted psychotherapy to be their central activity and no longer wanted psychiatrist supervision. Although psychiatry claimed psychologists lacked proper training, psychologists ended psychiatry's monopoly on psychotherapy by the end of the 1950s (7).
While psychologists were battling psychiatrists for the right to conduct psychotherapy, modern psychopharmacology emerged as a major force in mental health care. Between 1950 and 1960, many of the psychotropic medications in use today were introduced (for example, chlorpromazine, tricyclic antidepressants, and benzodiazepines) (8) . At the time, clinical psychologists criticized their efficacy by arguing that they only treated the symptoms of a disorder, not the underlying psychological disturbance (9). Psychology's theoretical approach to mental illness, unlike psychiatry's, did not promote a disease model of mental illness, but rather emphasized applying psychological-based theories to the understanding and treatment of mental disorders (10) . Consequently, the APA expended little effort at the time to obtain PPs for clinical psychologists, and licenced physicians retained sole right to prescribe medication.
Who Can Legally Prescribe?
In the US, determining the practitioners with the authority to prescribe medication generally occurs at the state level. Through their respective pharmacy and medical practice acts, each state determines which professions are authorized to prescribe (11) . In Canada, the Federal Bureau of Human Prescription Drugs decides how drugs are sold, and provincial legislatures determine which professions may prescribe. A 2-factor classification scheme for PPs was established to specify the degree of prescriptive authority held by a particular profession. The first dimension (independent vs dependent) pertains to whether physician supervision is required to prescribe. The second dimension (limited vs unlimited) concerns what categories of drugs may be prescribed (12) . Only physicians have independent and unlimited PPs in the US, but Canada grants independent and unlimited privileges to both physicians and dentists. Over the years, various professions have been granted limited PPs in the US, such as dentists, optometrists, and podiatrists. Prescriptive authority for these professions is limited typically to medications that affect body parts in their area of practice (11) . The APA is currently advocating for independent privileges, which would be limited to prescribing psychoactive medications.
Other nonphysicians who may be granted some degree of prescriptive authority are called "physician extenders." Professions that fall into this category include nurse practitioners, pharmacists, and physician assistants, whose prescriptive authority depends on physician supervision and is limited to specific drugs or drug formularies (13) . Note that in Canada, however, that although podiatrists have limited PPs in the province of Alberta, no other nonphysician disciplines may prescribe medication in this country.
Forces Driving the Prescription Privilege Debate
Understanding the nature and timing of the PP debate involves recognizing that it is occurring in a larger context of change within and around the practice of professional psychology. For years, psychologists have devoted time and energy to making psychotherapy their central activity, perhaps to the detriment of equally important activities such as research and developing preventive interventions. Now, psychologists face the possibility that they are no longer required to fulfill their psychotherapeutic role. Research shows that in most circumstances, a doctoral-level psychologist need not deliver psychotherapy to be effective (14, 15) . Presently, the field includes master's-level psychologists, doctorate-level psychologists, and ever-expanding groups of mental health professionals who also conduct psychotherapy, namely social workers, nurses, marriage and family counsellors, occupational therapists, and sex therapists (10) .
Economic factors are also fuelling the debate. Since the end of the 1980s, the governing force in mental health services in both Canada and the US has been cost containment. Although Canada's health care system has been managed publicly for decades, the need to reduce health care costs in the US has contributed to the creation of health maintenance organizations (HMOs) (16). Canada's publicly operated system and the rise of managed care systems in the US are essentially leading to the replacement of doctoral-level psychotherapists with less costly psychotherapists, whenever possible (17, 18) . Although doctoral-level psychologists may still be required for training and supervision, there is no longer a reason to use them as front-line service providers. From a cost-containment perspective, we expect that this situation will continue as long as third-party payers decide who conducts psychotherapy.
Similarly, the rising importance of mental health to pharmaceutical companies, who have a clear financial interest in the expansion of prescription authority, is stimulating the debate. Psychoactive medications now occupy a significant portion of the drug portfolios of major pharmaceutical firms, and drug companies are eager to see the use of such drugs expand (18) . Not surprisingly, the APA's Division of Psychologists in Independent Practice has been sustaining relations with the pharmaceutical industry over the past few years (19) , and there has been a dramatic increase in drug companysponsored symposia for psychologists and training grants for research "with a strong psychopharmacology emphasis" (20) .
Should Psychologists Be Granted Prescription Privileges?
The following section reviews the major arguments of APA representatives and both Canadian and American psychologists in favour of PPs, followed by a section discussing the weaknesses of those arguments. Further, we discuss the implications of PPs for professional psychology and psychology.
Arguments in Favour of Prescription Privileges
One of the most popular arguments put forth by PP advocates is that psychologists do not and cannot function as independent professionals because the medical profession places many restrictions on their practice in such areas as hospital privileges, insurance reimbursement, and PPs (1,2). Advocates assert that obtaining PPs would help increase the scope of psychological practice by helping psychologists expand their practice into settings that are traditionally dominated by physicians, such as nursing homes, long-term care facilities, and hospital-inpatient services (3, 21) .
To support this argument, advocates assert that because doctoral-level psychologists have more education than do other professionals who have secured various degrees of prescriptive authority (for example, nurse practitioners and pharmacists), psychologists should qualify for privileges (22, 23) . In fact, it is generally accepted by both proponents and opponents of PPs, that with the proper curriculum, psychologists could be trained to prescribe psychoactive medication (2, 18, 24) . Evidence emanating from both the Department of Defence Psychopharmacology Demonstration Project (PDP) and the Indian Health Service (IHS) shows that psychologists have been trained successfully to prescribe psychoactive medication (11, (24) (25) (26) .
A second major argument in favour of PPs relates to the limited mental health training of general practitioners (GPs) (3, 12, 22) . A recent survey revealed that, of the 135.8 million prescriptions issued for psychoactive medications in 1991, psychiatrists issued only 17% of those prescriptions. The remaining 83% were issued by GPs who typically receive only 4 to 12 weeks' training in mental health (27) (28) (29) . Mental health training for Canadian physicians appears consistent with this figure (12) . Equally disturbing is the fact that many patients seen by GPs and other nonpsychiatric specialists are frequently misdiagnosed and prescribed medication unnecessarily. Research shows that, in women alone, depression is misdiagnosed 30% to 50% of the time, and when antidepressants are prescribed, patients are often improperly monitored (30) . Given these data, proponents of PPs argue that appropriately trained doctoral-level psychologists would be more qualified to diagnose mental disorders, prescribe appropriate medication, and monitor the behavioural effects of such medication than would nonpsychiatrist practitioners (2).
Further, proponents point out that the reason so many GPs prescribe psychoactive medication is due to the relative unavailability of psychiatrists. Thus, advocates claim that granting PPs to psychologists would benefit those who have limited access to psychiatrists (11, 31) . Similarly, it is argued that PPs will enable psychologists to provide needed mental health services to underserved segments of society, such as minority children, those living in rural areas, and those living in chronic care facilities (11, 31, 32) .
Advocates for PPs argue that, because many patients receiving psychotherapy will consult a psychiatrist for pharmacologic treatment, it would be less disruptive to have 1 treatment provider (a psychologist) who can both prescribe and conduct therapy. They argue that being forced to consult 2 professionals with potentially contrasting views on how to direct patient care could compartmentalize treatment and force patients into "divided loyalties" (33) (34) (35) . The result is inefficient treatment dissemination and, ultimately, diminished treatment efficacy. Proponents add that granting prescriptive authority to psychologists would also result in decreased health care costs; psychologists charge an average of 14% less than do psychiatrists for the same service (36) . Therefore, proponents believe PPs for psychologists would facilitate both treatment and recovery at a lower cost.
A final point argued extensively in the literature is that medications can influence behaviour. In fact, this is a major target of psychological research and practice; for this reason, prescribing medications should become part of the practice of psychology (11, 13, 22) .
Arguments Against Prescription Privileges
Although proponents have presented several compelling arguments in support of granting PPs to psychologists, their arguments suffer from several important weaknesses. First, the argument that PPs would help psychologists gain professional autonomy by expanding their scope of practice into settings traditionally dominated by physicians has little empirical basis. This argument assumes that PPs will lead to 1) the cessation or reduction of physician control over inpatient services and 2) a dramatic increase in the number and type of clients psychologists can treat. It is unlikely, however, that PPs will impact which profession controls inpatient services. In short, control and, ultimately, responsibility of inpatient services is a public policy issue that is totally independent of the prescription privilege issue. Finally, physicians have been opposed to hospital privileges and any related pursuits thought to encroach on what they have considered to be their turf for years (10, 37) . Any endeavour that threatens to reduce their power over inpatient and hospital services will likely be met with a fight. To automatically equate PPs with physician-like control over mental health services is therefore perhaps overly optimistic.
Second, although there is some evidence demonstrating psychologists' competence to prescribe, the quality of that competence appears to vary according to the source of the report. For example, DeLeon, Folen, and others (24) reported that no quality of care problems were revealed following the Defence Department's PDP and concluded that psychologists could be trained as competent prescribers. Conversely, the American Psychiatric Association's Legislative Newsletter (12) reported that the doctoral-level psychologists who participated in the PDP received grades in conventional medical and pharmacological courses that ranged from C-to F. These grades likely reflect the psychologists' lack of training in basic sciences (for example, molecular biology, organic chemistry, and physiology), which currently are not required for admission to psychology graduate programs. A notable difference between psychologists and the nonphysician professions with limited PPs is that they all have a solid biological science background, which most psychology graduate programs do not provide (38) . In fact, a recent survey of graduate students revealed that only 7% had completed the minimum number of undergraduate science prerequisites necessary to undertake psychopharmacology training, as stipulated in proposed training models (39) . Further, surveys of graduate training directors revealed that 62% to 75% preferred not to train psychology students to prescribe at the doctoral level, stating that it would interfere significantly with current programs (40, 41) . As a result, currently most doctoral students and psychology training programs in the US and Canada are illprepared or unwilling to pursue psychopharmacological psychology as a subspecialty.
Some evidence documents psychologists' competence to prescribe, but it is difficult to generalize from so few data. To date, the literature has published the results of 2 American projects (the PDP and IHS) (25, 26) , and we are unaware of any published trials emanating from Canada. Besides, the sample sizes (n = 4 and n = 1, respectively), upon which conclusions concerning competence have been drawn, have been small. Clearly, we need more evidence before concluding that psychologists are capable of prescribing psychoactive medication safely and effectively.
The argument that focuses on the limited mental health training of GPs, although convincing, disregards the extensive medical and pharmacologic training of these physicians, which is a minimum of 4 to 6 years. Further, given that GPs are the front-line service providers under the current system, it is unlikely that PPs for psychologists would significantly alter health care-seeking behaviour or the number of prescriptions written by GPs, unless GPs decide to refer their patients to psychologists for pharmacologic treatment. Rather than adding psychologists to the long list of professionals who can already prescribe, a more constructive solution would be to provide greater mental health training for front-line service providers and to promote greater collaboration between GPs and psychologists.
Psychologists with PPs could help respond to the mental health care needs of underserved segments of the population (those living in rural or regional areas); however, the profession of physician assistant was created to serve such populations, but only 3% actually do (42) . Advocates have not yet produced data indicating the number of psychologists seeking PPs for this purpose or the number of psychologists who would relocate to provide services to a rural population.
Advocates for PPs have argued that having a psychologist who can both conduct psychotherapy and prescribe would be less disruptive and more effective than consulting both a psychologist and a psychiatrist with "potentially contrasting views." However, this argument assumes that psychologists would be more qualified than would psychiatrists to fulfill this dual role. If proponents are arguing a lack of collaboration between psychologists and psychiatrists, the solution appears to be improving collaboration (for the benefit of the patient) and not restructuring the practice of psychology.
The assertion that PPs for psychologists would result in lower mental health care costs is unlikely, given that psychologists would be in a position (and would likely be highly motivated) to raise their fees to reflect their new skills. This assertion is even more unlikely if you consider how insurance premium costs for psychologists would likely increase in line with their new responsibilities and potential liabilities. Interestingly, proponents of PPs discuss these issues rarely.
Proponents assert that because medications influence behaviour, prescribing medications should become part of psychological practice (11, 13, 22) . Subscribing to this argument, however, implies that psychologists should be able to adopt any physical intervention that could affect behaviour or psychological functioning, including neurosurgery or electroconvulsive therapy. The boundaries that the different mental health professions place on their scope of practice are what define each profession, and these boundaries promote competency and quality of care among treatment providers.
Rarely discussed among advocates of PPs is the enormous responsibility associated with having prescriptive authority, even if that authority is limited to psychoactive medication. One common problem associated with taking psychoactive medication is that many patients experience unpleasant and sometimes severe side effects, which often require appropriate medical treatment (for example, nausea, constipation, sexual dysfunction, abnormal heart rhythms, orthostatic hypotension, and hypertension) (43) . Psychologists, of course, would be limited to prescribing psychoactive medication and thus forced to refer their patient to a physician for treatment of side effects. In addition, there is the issue of potentially dangerous drug interactions, knowledge of which is crucial for patient health and safety. In other words, psychologists pursing PPs would require extensive knowledge of drug interactions involving the entire pharmacologic spectrum, which has never been the domain of psychology.
Also, rarely discussed in the literature is the potential for selfprescription among psychologists. Given the disproportionally high rate of suicide resulting from self-prescription overdoses among health professionals (for example, dentists and physicians) (44) (45) (46) , this issue warrants further debate before we open the door to thousands of additional prescribers.
Effects on the Professions of Psychology and Psychiatry
One of the most fundamental and often ignored issues with respect to PPs is the profound effect on the definition and future direction of professional psychology and psychiatry. Psychology has historically been identified with treatments based on psychological principles (47) . The Psychology Profession Act of Canada (48) specifically defines the practice of psychology as "the application of professional psychological knowledge for the purpose of diagnosing, preventing, remedying or ameliorating human mental, emotional, behavioural, or relationship difficulties and to enhance human performance and mental or physical health." According to this definition, psychology's principal activities involve psychological and behavioural interventions based on psychological knowledge, not psychiatric or pharmacologic knowledge; thus, prescribing psychoactive medication clearly falls outside the boundaries of what has been considered psychological practice.
If psychologists were permitted to add medication to the list of interventions they currently use, the underlying rationale and organizing principles of both psychology and psychiatry would be fundamentally altered. Psychiatry is a medical discipline, focusing on the diagnosis and treatment of mental disease; psychology was originally conceived as an academic discipline. Only later did it evolve to include psychological, cognitive, and behavioural approaches to both evaluating and treating mental illness. Psychology, however, has grown to develop innovative and effective treatments for several mental disorders, which should remain distinct from psychiatric approaches.
Conclusions
The debate on whether psychologists should be granted PPs is still in its infancy. Pilot projects relating to feasibility and efficacy are either sparse or incomplete. Although proponents present several compelling arguments in favour of PPs for psychologists, it is too soon to tell whether PPs could or should be pursued. What is clear is that this debate will have a profound impact on both professional psychology and psychiatry-but one that is likely to take years to unfold.
In the meantime, psychologists could concentrate their efforts on improving both the professional and public dissemination of the services they already provide. For example, they could work on improving collaboration with GPs and psychiatrists to ensure that medicated patients are properly monitored and advised of available psychotherapy options. Psychologists need not go beyond the boundaries of psychological practice to expand into new treatment areas. There have already been important advances in the areas of health psychology and behavioural medicine, wherein psychologists have demonstrated success in improving treatment adherence and disease outcome in cancer patients (49) (50) (51) , coronary artery disease patients (52, 53) , and HIV sufferers (54, 55) , all using psychological interventions. Expanding the quality and scope of existing psychological therapies, rather than expanding services to include PPs, may represent more promising and appropriate goals for psychology at the present time.
Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists
Résumé : Doit-on accorder aux psychologues le privilège de prescrire? une étude du débat sur le privilège de prescrire à l'intention des psychiatres Contexte : Le débat sur la question d'accorder ou non aux psychologues cliniques le droit de prescrire des psychotropes a reçu une attention considérable au cours des 20 dernières années aux États-Unis, mais il y a eu relativement peu de discussions sur ce sujet controversé parmi les professionnels de la santé mentale canadiens, notamment les psychologues et psychiatres. Les partisans du privilège de prescrire (PP), y compris l'American Psychological Association (APA), font valoir que les psychologues ne fonctionnent pas comme des professionnels indépendants et ne peuvent le faire parce que la profession médicale impose de trop nombreuses restrictions à leur pratique. On croit que le PP aiderait à contourner la marginalisation imminente de la psychologie professionnelle en augmentant la portée de la pratique de la psychologie. Les partisans soutiennent également que le PP améliorerait les services de santé mentale en élargissant l'accès du public aux professionnels qui peuvent prescrire.
Objectif : Le but de cet article est d'informer les psychiatres sur les principaux arguments présentés en faveur et en défaveur du privilège de prescrire (PP) pour les psychologues, et de discuter des principales implications du PP tant pour la psychologie professionnelle que pour la psychiatrie.
Méthodes : Nous avons mené une recherche des articles pertinents de la documentation dans les bases de données Psychlit et Medline, publiés de 1980 à aujourd'hui, à l'aide des mots clés « privilège de prescrire et psychologues ».
Conclusion :
Bien que les partisans présentent plusieurs arguments convaincants en faveur du PP pour les psychologues, les projets pilotes sur la faisabilité et l'efficacité sont soit rares, soit incomplets. Ainsi, il est trop tôt pour dire si l'on peut ou doit poursuivre le PP. Il est évident qu'il faut d'autres études avant de conclure que le PP pour les psychologues est une solution sûre et nécessaire à la présumée marginalisation imminente de la psychologie.
